Concepedia

Lucy Barker

LB

Statistics

Publications

6

Citations

195

H-Index

6

Active since

1979

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (United Kingdom)

Royal Society for the Prevention of Cruelty to Animals

Lucy Barker is an author at Novartis (Switzerland) specializing in medicinal chemistry, pharmacology, and potency optimization.

Publications per year

1979–2017

6

Publications

6

Sterigmatocystin-DNA interactions: identification of a major adduct formed after metabolic activation in vitro.

John M. Essigmann, Lucy Barker, Kerry W. Fowler et al. · Proceedings of the National Academy of Sciences · 1979 · 54 citations · Full text

, , +15

7-Azaindole-3-acetic acid derivatives: Potent and selective CRTh2 receptor antagonists

David A. Sandham, Claire Adcock, Kamlesh Bala et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 44 citations · Full text

, , +7

Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma

David A. Sandham, Lucy Barker, Lyndon Brown et al. · ACS Medicinal Chemistry Letters · 2017 · 35 citations · Full text

, , +11

Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases

David A. Sandham, Nicola Arnold, Heinrich Aschauer et al. · Bioorganic & Medicinal Chemistry · 2013 · 22 citations · Full text

, , +9

Synthesis and biological properties of novel glucocorticoid androstene C-17 furoate esters

David A. Sandham, Lucy Barker, David T. Beattie et al. · Bioorganic & Medicinal Chemistry · 2004 · 22 citations

, , +8

1–5 of 6